CannIntelligence open content

Luxembourg’s recreational cannabis plan likely to go the same way as Germany’s

Written by CannIntelligence | 8th June 2023

Germany’s recent announcement that it has scaled back its plans to legalise recreational cannabis could have a knock-on effect on its smaller neighbour Luxembourg’s planned pilot programme ...

A question of Czechs and balances – the most compelling legal saga now showing

Written by Freddie Dawson | 8th June 2023

The Czech government is still knee deep in trying to create a recreational cannabis market, but it looks like tightening up enforcement on tangential areas is no longer as much of a concern ...

Canadian cannabis policies give the lawbreakers an edge, says watchdog

Written by CannIntelligence | 1st June 2023

Canada’s Competition Bureau says federal government policies are making it more difficult for the country’s fledgling legal cannabis industry to compete with the illegal market ...

Researchers’ direst warnings on oral CBD should be taken with a lethal dose of salt

Written by CannIntelligence | 25th May 2023

Researchers at the US Food and Drug Administration (FDA) recently published a review on the toxicity of orally-consumed CBD, largely echoing worries outlined in other safety reviews. So how worried should we be? ...

Czech government stops ban on CBD-containing food products before it starts

Written by Tiziana Cauli | 22nd May 2023

The Czech government will no longer go forward with a proposed measure to ban sales of food products containing CBD which was due to come into effect in mid-June ...

Another left-field throw as Czechs keep us guessing on cannabinoids policy

Written by Freddie Dawson | 18th May 2023

The Czech Republic has taken another interesting U-turn, announcing then almost at once retracting a ban on CBD foods – but what might it all mean for recreational cannabis, or IHDCs? ...

22nd Century forecasts full-year sales upward of $105m after Q1 records

Written by Antonia Di Lorenzo | 12th May 2023

US-based 22nd Century reported record cannabinoid ingredient volumes delivered in the first quarter of 2023 and expects those to increase further throughout the year ...

How will legalising recreational use affect Germany’s medical cannabis market?

Written by Lorraine Mullaney | 11th May 2023

German recreational legalisation – despite being watered down – will still heavily impact, but not completely eliminate, the country’s medical cannabis market ...

Podcast: Groundbreaking win for hemp in Poland’s high court

Written by CannIntelligence | 10th May 2023

Kombinat Konopny CEO and founder Maciej Kowalski talks to podcast host Oliver Prescott about the company’s win in Poland’s high court, subsequent changes in the industry and current cannabis food policy in Europe ...

As drinkers move away from alcohol, how far can cannabis drinks penetrate?

Written by CannIntelligence | 4th May 2023

Increasing numbers of consumers are shifting away from alcohol in favour of healthier and lower-alcoholic options, which many have perceived as an opportunity for cannabinoid-containing drinks ...

‘We can’t make medical claims’ is a way of making a medical claim, says watchdog

Written by Freddie Dawson | 27th April 2023

Referring to the fact that a CBD company cannot make medical claims can itself be construed as making a medical claim, according to the UK Advertising Standards Authority ...

The pay and the pain – study reveals little about the real value of medical cannabis

Written by CannIntelligence | 20th April 2023

A new study of the relationship between opioids and cannabis via payments to doctors in US states offers little towards understanding the potential of cannabis as a substitute for opioids ...

Belgium to outlaw sales of cannabinoid and nicotine pouches later this year

Written by CannIntelligence | 14th April 2023

The sale of cannabinoid pouches in Belgium has been banned along with nicotine pouches on the grounds the latter pose a danger to public health, particularly due to their potential for addiction ...

IMC 2022 revenue up 60% as it leaves Canada, focuses on Israel and Germany

Written by Antonia Di Lorenzo | 11th April 2023

International cannabis company IM Cannabis (IMC) reported a significant rise in its revenue for the whole of 2022 as well as the last quarter of the year ...

Cannabis good, or cannabis bad? However you see it, we’ve got a stat for that

Written by Aidan Semmens | 6th April 2023

While statistics are vital to understanding our world, they are often misunderstood – and that can be important when it comes to forming opinions and laws on controversial issues such as cannabis ...

Two Buttes put their heads together to save the world with plenty of weed!

Written by CannIntelligence | 1st April 2023

Cannabinoids have been credited with many benefits to individual health. But now industry stakeholders are wondering if the hemp plant could be applied to an even bigger task – saving the planet ...

Tobacco giant Altria considers cannabis for its non-nicotine product offering

Written by Tiziana Cauli | 31st March 2023

Altria is considering including cannabis as well as caffeine pouches in its offering of non-nicotine products as part of its growth strategy ...

Yellow card offence – but comments are a long way from being a dismissal of CBD

Written by CannIntelligence | 22nd March 2023

Comments by the chair of the UK Committee on Toxicity (COT) about reactions to CBD have stirred up a hornet’s nest – but the furore suggests a misunderstanding of what he actually said ...

Mayhem in Mexico as agency grants firm hemp licence then vows to take it back

Written by CannIntelligence | 16th March 2023

A firm that was granted permission to grow and make products from industrial hemp in Mexico was immediately warned by regulators that they would appeal against their own decision ...

Relaxation beats intoxication – IHDC sales aren’t just about getting high

Written by Freddie Dawson | 15th March 2023

HHC is the most popular intoxicating hemp-derived cannabinoid (IHDC) in Europe, while delta-8 THC remains top in the US, according to CannIntelligence analysts ...